Articles

PVR-Vol-9-2_what-to-learn-from-US-FDA_Gandelman_Sciformix_Nov2016.pdf

Drug safety and pharmacovigilance (PV) are paramount to the development of new drugs and the continued use of approved medications. **Disclaimer: This article was previously published. Sciformix is now a Covance company.

Filed In

Articles